Dongwha Pharm.Co

Dongwha Pharm.Co, established in 1897, is a distinguished South Korean pharmaceutical entity focused on the development and manufacturing of a comprehensive array of medications and healthcare products. With a legacy spanning over a century, the company is committed to delivering high-quality pharmaceutical solutions to healthcare providers and patients alike. Operating within the Pharmaceuticals and Healthcare industries, Dongwha Pharm.Co's mission is to enhance public health through innovative and reliable medical treatments. Its product portfolio includes essential prescription drugs, accessible over-the-counter medications, and beneficial health supplements, catering to a broad spectrum of health needs. The company's deep-rooted expertise and continuous pursuit of excellence solidify its position as a trusted name in the pharmaceutical sector.

The company's operational framework is designed to efficiently serve its target markets, which primarily consist of hospitals, clinics, and pharmacies. Dongwha Pharm.Co employs a dedicated workforce of 500 - 1,000 professionals who drive its research, development, and production efforts. With a presence indicated by 2 locations, the company maintains a focused operational footprint. To understand the human capital driving these advancements, one can Meet Dongwha Pharm.Co's team and learn about their leadership and expertise. This team's collective efforts are instrumental in upholding the company's standards and expanding its therapeutic offerings.

Dongwha Pharm.Co is recognized by its ticker KRX: 000020 and generates significant revenue, with its latest reported figure standing at $274.0M. The company's market presence extends across the Asia Pacific region, reflecting its strategic geographic focus. Its business model is predominantly B2B, serving other entities within the healthcare ecosystem. TheView more...